help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watson, P. F.
Right arrow Articles by Weetman, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watson, P. F.
Right arrow Articles by Weetman, A. P.

Journal of Clinical Endocrinology & Metabolism, Vol 79, 355-360, Copyright © 1994 by Endocrine Society


ARTICLES

Analysis of cytokine gene expression in Graves' disease and multinodular goiter

PF Watson, AP Pickerill, R Davies and AP Weetman
Department of Medicine, University of Sheffield Clinical Sciences Center, Northern General Hospital, United Kingdom.

Cytokines have a central role in the generation of an autoimmune response and can directly affect the target organ. In Graves' disease, both the infiltrating mononuclear cells and the thyroid follicular cells produce certain cytokines, but the relative contribution of each is unclear, and there are conflicting data on the exact profile of cytokines expressed within the thyroid. To clarify these issues, we used the method of reverse transcription-polymerase chain reaction amplification to analyze cytokine gene expression by intrathyroidal lymphocytes (ITL) and purified thyroid follicular cells (TFC) from six patients with Graves' disease. All ITL samples were positive for interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-6, IL-8, IL-10, and tumor necrosis factor-alpha (TNF alpha) messenger ribonucleic acids (mRNAs). Four samples were positive for IL-2 mRNA, and of these, three were also positive for interferon-gamma (IFN gamma). All TFC samples contained IL-6 and IL-8 mRNAs, even after depletion of CD3-positive T- cells. One TFC sample was additionally positive for IL-10 and TNF alpha mRNAs, and in the case of IL-10, this signal was not eliminated by CD3- positive T-cell depletion. IL-4 was not detected in any sample of ITL, TFC, or whole tissue. Semiquantitative analysis showed that the ITL fraction represented the major source of IL-6, IL-8, and TNF alpha mRNAs. By contrast, only three of five multinodular goiter samples were positive for IL-1 alpha mRNA; of these, two were also positive for IL- 6, and 1 was positive for IL-8 mRNA. One multinodular goiter sample was positive for IL-8 mRNA alone, but IL-2, IL-4, IL-10, and TNF alpha mRNAS were not detected. These results suggest that although the TFC themselves may express certain cytokines, the ITL population represents the most important source of cytokine production in Graves' thyroid glands. The presence of IL-2, IFN-gamma, and TNF alpha and the absence of IL-4 mRNA in samples of ITL indicate a pattern of cytokine production that most closely resembles that of the TH1 helper T-cell subset. Given the etiological role of thyroid-stimulating antibodies in Graves' disease, the production of which is likely to depend upon TH2 helper T-cell function, it is perhaps surprising that the TH1 subset appears to predominate. It is possible that IL-10 is important in stimulating intrathyroidal autoantibody production, and this cytokine may also play a role in inhibiting cell-mediated thyroid injury in Graves' disease.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Antonelli, M. Rotondi, S. M. Ferrari, P. Fallahi, P. Romagnani, S. S. Franceschini, M. Serio, and E. Ferrannini
Interferon-{gamma}-Inducible {alpha}-Chemokine CXCL10 Involvement in Graves' Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-{gamma} Agonists
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 614 - 620.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Mazziotti, F. Sorvillo, M. Piscopo, F. Morisco, M. Cioffi, G. Stornaiuolo, G. B. Gaeta, A. M. Molinari, J. H. Lazarus, G. Amato, et al.
Innate and Acquired Immune System in Patients Developing Interferon-{alpha}-Related Autoimmune Thyroiditis: A Prospective Study
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4138 - 4144.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A. Antonelli, M. Rotondi, P. Fallahi, P. Romagnani, S. M. Ferrari, A. Paolicchi, E. Ferrannini, and M. Serio
Increase of interferon-{gamma} inducible {alpha} chemokine CXCL10 but not {beta} chemokine CCL2 serum levels in chronic autoimmune thyroiditis
Eur. J. Endocrinol., February 1, 2005; 152(2): 171 - 177.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
W. B. Chan, C. C. Chow, and C. S. Cockram
Interferon alpha treatment and endocrine disease
J R Soc Med, October 1, 2003; 96(10): 481 - 485.
[Full Text] [PDF]


Home page
EndocrinologyHome page
A. G. Gianoukakis, L. J. Martino, N. Horst, W. W. Cruikshank, and T. J. Smith
Cytokine-Induced Lymphocyte Chemoattraction from Cultured Human Thyrocytes: Evidence for Interleukin-16 and Regulated upon Activation, Normal T Cell Expressed, and Secreted Expression
Endocrinology, July 1, 2003; 144(7): 2856 - 2864.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
E H Kemp, R A Metcalfe, P F Watson, and A P Weetman
HLA-G does not have a pathophysiological role in Graves' disease
J. Clin. Pathol., June 1, 2003; 56(6): 475 - 477.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Hiromatsu, D. Yang, T. Bednarczuk, I. Miyake, K. Nonaka, and Y. Inoue
Cytokine Profiles in Eye Muscle Tissue and Orbital Fat Tissue from Patients with Thyroid-Associated Ophthalmopathy
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1194 - 1199.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Schuppert, D. Ehrenthal, A. Frilling, K. Suzuki, G. Napolitano, and L. D. Kohn
Increased Major Histocompatibility Complex (MHC) Expression in Nontoxic Goiters Is Associated with Iodide Depletion, Enhanced Ability of the Follicular Thyroglobulin to Increase MHC Gene Expression, and Thyroid Autoantibodies
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 858 - 867.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Arao, I. Morimoto, A. Kakinuma, O. Ishida, K. Zeki, Y. Tanaka, N. Ishikawa, K. Ito, K. Ito, and S. Eto
Thyrocyte Proliferation by Cellular Adhesion to Infiltrating Lymphocytes through the Intercellular Adhesion Molecule-1/Lymphocyte Function-Associated Antigen-1 Pathway in Graves' Disease
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 382 - 389.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. M. Jones, C. C. H. Kwok, and A. W. C. Kung
Effect of Radioactive Iodine Therapy on Cytokine Production in Graves' Disease: Transient Increases in Interleukin-4 (IL-4), IL-6, IL-10, and Tumor Necrosis Factor-{alpha}, with Longer Term Increases in Interferon-{gamma} Production
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4106 - 4110.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Ashhab, O. Dominguez, M. Sospedra, C. Roura-Mir, A. Lucas-Martín, and R. Pujol-Borrell
A One-Tube Polymerase Chain Reaction Protocol Demonstrates CC Chemokine Overexpression in Graves' Disease Glands
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2873 - 2882.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Kromminga, C. Hagel, R. Arndt, and F. Schuppert
Serological Reactivity of Recombinant 1D Autoantigen and Its Expression in Human Thyroid and Eye Muscle Tissue: A Possible Autoantigenic Link in Graves' Patients
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2817 - 2823.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
T. Kikumori, F. Kambe, T. Nagaya, T. Imai, H. Funahashi, and H. Seo
Activation of Transcriptionally Active Nuclear Factor-{kappa}B by Tumor Necrosis Factor-{alpha} and Its Inhibition by Antioxidants in Rat Thyroid FRTL-5 Cells
Endocrinology, April 1, 1998; 139(4): 1715 - 1722.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. A. Ajjan, P. F. Watson, and A. P. Weetman
Detection of IL-12, IL-13, and IL-15 Messenger Ribonucleic Acid in the Thyroid of Patients with Autoimmune Thyroid Disease
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 666 - 669.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Lakatos, J. Foldes, C. Horvath, L. Kiss, A. Tatrai, I. Takacs, G. Tarjan, and P. H. Stern
Serum Interleukin-6 and Bone Metabolism in Patients with Thyroid Function Disorders
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 78 - 81.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society